Reading time: 07 minutes
Team PSP | 17/11/2022
The integration of Artificial Intelligence (AI) into our healthcare systems is no longer a futuristic concept—it is a 2022 reality. From streamlining drug discovery to refining gene editing, AI and Big Data are fundamentally reshaping the patient experience. Recent studies even suggest that AI can now outperform clinicians in specific tasks, such as detecting early-stage breast cancer in mammograms or identifying arrhythmias in ECG data.
However, as we embrace this “algorithmic era,” the medical community is grappling with profound technical and legal questions. How do we protect patients from a defective “digital diagnosis”? How do we secure sensitive data? And, perhaps most urgently, how do we eliminate the historical biases—racial, gender-based, and socioeconomic—baked into the very data used to train these systems?
The Pillars of AI in Today’s Medical Landscape
AI is not a monolith; it is an amalgamation of specialized technologies that handle everything from back-office paperwork to microscopic surgery.
- Machine Learning (ML)
Machine learning remains the powerhouse of the sector. By processing massive datasets, ML identifies patterns that are often invisible to the human eye.
- Early Detection: ML is now being used to identify patients at high risk of sepsis or cardiac failure hours before clinical symptoms manifest.
- The Pandemic Legacy: In the wake of COVID-19, ML proved vital in analyzing trial data and optimizing vaccine distribution logistics.
- Physical Robotics: From Wards to the Micro-Scale
Robotics in 2022 is moving beyond the “mechanical arm” stage toward intuitive, healing systems.
- Support Bots: “Nursing robots” are now checking vitals and drawing blood, allowing human staff to focus on high-touch patient care.
- Surgical Exoskeletons: These are revolutionizing physical therapy, providing mechanized support to help patients regain mobility after severe spinal or limb injuries.
- The Micro-Revolution: We are seeing the rise of micro-robots—devices the size of a single human cell—that can navigate the bloodstream to perform repairs or deliver drugs, potentially ending the era of highly invasive surgeries.
- Natural Language Processing (NLP)
NLP allows computers to “read” and understand human speech and text. In 2022, this is primarily used to digitize the “unstructured” chaos of medical records. Techniques like Optical Character Recognition (OCR) are now standard for turning decades of handwritten clinical notes into searchable, actionable digital data.
- Robotic Process Automation (RPA)
If ML is the “brain,” RPA is the “hands.” RPA software handles the tedious, rule-based tasks that bog down healthcare.
- Cost Efficiency: Implementing RPA in medical insurance has shown a 30% reduction in claims processing costs.
- Efficiency Gains: By automating scheduling, institutions are seeing “no-show” rates drop—a critical metric since labor accounts for over 60% of hospital expenses.
The Bias Problem: Concrete Numbers and Hard Truths
As we rely more on algorithms, we must confront the fact that they are only as “fair” as the data they consume. In 2022, the medical community is sounding the alarm on algorithmic bias:
- Pulse Oximetry: Studies have confirmed that pulse oximeters can be 3x less accurate in detecting low oxygen levels in Black patients compared to white patients because the light sensors were primarily calibrated on lighter skin tones.
- Insurance Algorithms: One widely used commercial algorithm was found to be less likely to refer Black patients to high-risk care management programs. Because the algorithm used “historical healthcare spending” as a proxy for “health need,” it missed the fact that Black patients historically had less access to care, and therefore lower spending, despite having more severe illnesses.
- Gender Disparity: Clinical AI models often lack diversity; a recent systematic review found that 31% of global AI models did not even report the gender composition of their training data.
The FDA’s New Guardrails: The 2021 Action Plan
Recognizing that traditional regulations can’t keep up with “adaptive” software that learns in real-time, the FDA released its Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan in January 2021.
Key Regulatory Shifts in 2022:
- Total Product Lifecycle (TPLC): Instead of a one-time “pass/fail” check, the FDA is moving toward a framework that monitors a tool’s performance from development through its entire “real-world” use.
- Predetermined Change Control Plans (PCCP): Manufacturers can now submit a plan for how their algorithm will “learn” and change before it is deployed, allowing for faster, safer updates.
- Transparency Requirements: The FDA now demands clear documentation on “input data” and instructions. If a device was only trained on a specific population, that must now be disclosed to the clinician.
Conclusion: Seeking the “Digital Balance”
The goal for the remainder of 2022 is to strike a balance between fostering innovation and setting rigid guardrails. We are moving toward a future where “Good Machine Learning Practices” (GMLP) are as standardized as hand-washing in a surgical suite. While AI can process data faster than any human, the ultimate safety net remains a transparent, bias-aware partnership between the machine and the physician.